ipilimumab
bms
['melanoma', 'ipilimumab']
#til therapy for advanced #melanoma - shows striking results from their randomized phase iii trial comparing til with ipilimumab: improved pfs to 7 months with til therapy compared to 3 months with ipilimumab #esmo22 #presidentialsymposium 
Dr. | Biomedical Scientist | Editor @CellRepMed | Cycle Tourer | Mother of Little Dragons | Adventurer | Sailor | Matthijs&Kym*&Tygo&Remy | views my own